Rong-Zhen Luo

1.5k total citations
40 papers, 1.2k citations indexed

About

Rong-Zhen Luo is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Rong-Zhen Luo has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Surgery and 14 papers in Oncology. Recurrent topics in Rong-Zhen Luo's work include Esophageal Cancer Research and Treatment (11 papers), Cancer-related gene regulation (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Rong-Zhen Luo is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Cancer-related gene regulation (8 papers) and Gastric Cancer Management and Outcomes (6 papers). Rong-Zhen Luo collaborates with scholars based in China, United States and Hong Kong. Rong-Zhen Luo's co-authors include Mu-Yan Cai, Jing‐Ping Yun, Dan Xie, Jie-Wei Chen, Shi-Xun Lu, Jia Fu, Chris Zhiyi Zhang, Li-Li Liu, Jie‐Hua He and Hao‐Xian Yang and has published in prestigious journals such as PLoS ONE, Radiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Rong-Zhen Luo

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong-Zhen Luo China 20 737 346 274 230 216 40 1.2k
Keisuke Matsusaki Japan 20 566 0.8× 259 0.7× 385 1.4× 213 0.9× 245 1.1× 43 1.1k
Le Qu China 20 884 1.2× 644 1.9× 234 0.9× 415 1.8× 153 0.7× 61 1.4k
Susheng Shi China 19 745 1.0× 627 1.8× 406 1.5× 184 0.8× 190 0.9× 49 1.2k
Takehiro Hayashi Japan 15 394 0.5× 215 0.6× 333 1.2× 126 0.5× 125 0.6× 44 937
Daisuke Obinata Japan 21 483 0.7× 248 0.7× 192 0.7× 324 1.4× 251 1.2× 63 1.0k
Tingguo Zhang China 26 626 0.8× 276 0.8× 451 1.6× 361 1.6× 404 1.9× 67 1.5k
Zhongwen Zhou China 17 585 0.8× 526 1.5× 235 0.9× 132 0.6× 221 1.0× 39 1.0k
Anna Sankila Finland 13 818 1.1× 186 0.5× 261 1.0× 282 1.2× 171 0.8× 20 1.2k
Jan Åkervall Sweden 20 564 0.8× 224 0.6× 418 1.5× 164 0.7× 187 0.9× 44 1.1k

Countries citing papers authored by Rong-Zhen Luo

Since Specialization
Citations

This map shows the geographic impact of Rong-Zhen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong-Zhen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong-Zhen Luo more than expected).

Fields of papers citing papers by Rong-Zhen Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong-Zhen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong-Zhen Luo. The network helps show where Rong-Zhen Luo may publish in the future.

Co-authorship network of co-authors of Rong-Zhen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Rong-Zhen Luo. A scholar is included among the top collaborators of Rong-Zhen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong-Zhen Luo. Rong-Zhen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Mu-Yan, Feng-Wei Wang, Chang-Peng Li, et al.. (2016). Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chinese Journal of Cancer. 35(1). 80–80. 14 indexed citations
2.
Zhou, Yun, et al.. (2015). Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits. Drug Design Development and Therapy. 9. 5949–5949. 3 indexed citations
3.
Hou, Xue, Jin-Chang Wei, Jianhua Fu, et al.. (2015). Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 22(11). 3666–3673. 10 indexed citations
4.
Luo, Rong-Zhen, et al.. (2015). Establishment of the retroperitoneal lymph node metastasis model of endometrial VX2 carcinoma in rabbits and observation of its metastatic features. World Journal of Surgical Oncology. 13(1). 109–109. 5 indexed citations
5.
Xu, Rui, et al.. (2015). The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma. JAMA Dermatology. 152(3). 305–305. 18 indexed citations
6.
Zhang, Xin-Ke, Miao Xu, Jie-Wei Chen, et al.. (2015). The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma. Tumor Biology. 36(7). 5201–5208. 9 indexed citations
7.
Ling, Yi-Hong, Shao-Yan Xi, Rong-Zhen Luo, et al.. (2014). Prognostic Significance of the pN Classification Supplemented by Vascular Invasion for Esophageal Squamous Cell Carcinoma. PLoS ONE. 9(4). e96129–e96129. 13 indexed citations
8.
Hou, Xue, Xue-Wen Liu, Jianhua Fu, et al.. (2014). The Impact of Tumor Cell Differentiation on Survival of Patients with Resectable Esophageal Squamous Cell Carcinomas. Annals of Surgical Oncology. 22(3). 1008–1014. 9 indexed citations
9.
Luo, Rong-Zhen, et al.. (2013). Prognostic analysis of early-stage squamous cell carcinoma of the vulva. World Journal of Surgical Oncology. 11(1). 20–20. 5 indexed citations
10.
Li, Mei, et al.. (2012). Clinicopathological investigation of four cases of desmoplastic small round cell tumor. Oncology Letters. 4(3). 423–428. 5 indexed citations
11.
Cao, Xun, Yong Li, Rong-Zhen Luo, et al.. (2012). Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery. 93(5). 1674–1680. 26 indexed citations
12.
Wang, Xin, Yi Liang, Qiong Chen, et al.. (2012). Prognostic Significance of SOX2 Expression in Nasopharyngeal Carcinoma. Cancer Investigation. 30(1). 79–85. 30 indexed citations
13.
Cai, Mu-Yan, Rong-Zhen Luo, Frank Yonghong Li, et al.. (2012). High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications. 426(4). 636–642. 15 indexed citations
14.
Hou, Xue, Jin-Chang Wei, Ying Xu, et al.. (2012). The Positive Lymph Node Ratio Predicts Long-Term Survival in Patients with Operable Thoracic Esophageal Squamous Cell Carcinoma in China. Annals of Surgical Oncology. 20(5). 1653–1659. 28 indexed citations
15.
16.
Luo, Kongjia, Jing Wen, Xuan Xie, et al.. (2012). Prognostic Relevance of Id-1 Expression in Patients With Resectable Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery. 93(5). 1682–1688. 14 indexed citations
17.
Yang, Hao‐Xian, Rong-Zhen Luo, Ying Zhang, et al.. (2011). High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery. 91(5). 1531–1538. 43 indexed citations
18.
Li, Yong, Zhe-Sheng Wen, Hao‐Xian Yang, et al.. (2011). High Expression of Y-Box-Binding Protein-1 is Associated with Poor Survival in Resectable Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 18(12). 3370–3376. 8 indexed citations
19.
Qiu, Miao‐Zhen, Hui Luo, Zhao-Lei Zeng, et al.. (2010). DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. Journal of Translational Medicine. 8(1). 126–126. 53 indexed citations
20.
Cai, Mu-Yan, Jing-Hui Hou, Hui-Lan Rao, et al.. (2010). High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients. Molecular Medicine. 17(1-2). 12–20. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keisuke Matsusaki Breakdown of academic impact, for papers by Le Qu Breakdown of academic impact, for papers by Susheng Shi Breakdown of academic impact, for papers by Takehiro Hayashi Breakdown of academic impact, for papers by Daisuke Obinata Breakdown of academic impact, for papers by Tingguo Zhang Breakdown of academic impact, for papers by Zhongwen Zhou Breakdown of academic impact, for papers by Anna Sankila Breakdown of academic impact, for papers by Jan Åkervall
Rankless by CCL
2026